|
Compact Navigation System for CT-guided Needle Interventions
|
1UT1CA224886-01A1
|
$149,927
|
|
TSE, TSZ HO
|
3T TECHNOLOGIES, LLC
|
|
Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer
|
1R44CA224718-01A1
|
$159,365
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Affinity Purification of Biologics with Mimetope Peptides
|
1R43CA228945-01
|
$217,898
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Personalized precision dosing of biologic therapies in oncology
|
5R44CA217336-02
|
$720,363
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Novel targeted therapy for pancreatic cancer
|
1R43CA221555-01A1
|
$299,979
|
|
HERRERA, VICTORIA
|
ABTELUM BIOMEDICAL, INC.
|
|
A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer
|
1R44CA224835-01A1
|
$298,864
|
|
PERICLE, FEDERICA
|
AGILVAX, INC.
|
|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
5R25CA186882-05
|
$135,579
|
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Central Africa International Epidemiologic Database to Evaluate AIDS
|
5U01AI096299-09
|
$260,000
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-05
|
$701,988
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-21
|
$581,591
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of macroH2A variants in cancer and senescence
|
5R01CA155232-08
|
$382,013
|
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-05
|
$346,525
|
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
5F30CA210539-03
|
$44,524
|
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-19
|
$417,500
|
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-04
|
$264,583
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
5F30CA203446-03
|
$49,524
|
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
5R44CA183362-03
|
$789,107
|
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
Methods in Clinical Cancer Research Workshop
|
5R25CA068647-21
|
$224,999
|
|
VON HOFF, DANIEL
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
The Political Economy of Tobacco Farming in Low-and Middle-Income Countries
|
5R01TW010898-07
|
$172,820
|
|
DROPE, JEFFREY
|
AMERICAN CANCER SOCIETY, INC.
|
|
Molecular, cancer-specific, intraoperative imaging of breast surgical margin assessment
|
1R41CA221595-01A1
|
$300,000
|
|
SHIH, WEI-HENG
|
AQD LIFE SCIENCES, LLC
|
|
Developing a mobile application for circadian wellness in cancer patients
|
1R43CA236557-01A1
|
$221,237
|
|
WALCH, OLIVIA
|
ARCASCOPE, LLC
|
|
Stand and Move at Work: A Group-Randomized Trial
|
5R01CA198971-04
|
$582,484
|
|
BUMAN, MATTHEW
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Immunosignatures to Distinguish Breast Cancer Subtypes and Cancer Recurrence
|
5R21CA220150-02
|
$123,600
|
|
JOHNSTON, STEPHEN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
5U01CA214201-03
|
$607,578
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-03
|
$655,095
|
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
|
5U01CA197902-04
|
$571,401
|
|
TASEVSKA, NATASHA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of IRF8 in Tumor Rejection and Suppression
|
5R01CA133085-09
|
$307,800
|
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression
|
5R01CA182518-05
|
$315,400
|
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-03
|
$1,063,923
|
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
|
5U01CA196386-05
|
$895,779
|
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-05
|
$307,736
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Consortium for large-scale production and phenotyping of knockout mice (UM1)
|
5UM1HG006348-08
|
$1,260,000
|
|
BEAUDET, ARTHUR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Crosstalk between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer
|
1R37CA228304-01
|
$362,569
|
|
CHEN, XI
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
5R01CA219667-02
|
$523,048
|
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
5K01CA190235-04
|
$140,400
|
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-04
|
$119,807
|
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Proteosome Inhibition Therapy for Hematologic Malignancy
|
5K23CA113775-03
|
$134,015
|
$67,008
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-04
|
$362,569
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-05
|
$2,251,410
|
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers
|
1R01CA216426-01A1
|
$427,819
|
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Hormonal Regulation of Breast Cancer
|
2R01CA016303-42A1
|
$480,181
|
|
ROSEN, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-03
|
$973,045
|
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-07
|
$985,145
|
$197,029
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
|
5R01CA184792-04
|
$347,517
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
|
5U01CA214254-02
|
$1,020,224
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-04
|
$388,875
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-05
|
$721,537
|
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
Total relevant funding to Multiple Myeloma for this search: $51,407,943
|